|
⚲
|
| Biolex Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001407698 |
| Sale | 2010-02-11 ($10.0 M Offered, $10.0 M Sold) |
| Fund | |
| Phone | 9195429901 |
| Address | 158 Credle Street Pittsboro, 27312 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Klaus Veitinger | |
| David Spencer | |
| P Neff | |
| Dennis Dougherty | |
| Kevin Bitterman | |
| Jeff Leiden | |
| Liza Page Nelson | |
| Dale Sander | |
| Jan Turek | |
| W Amick | |
| David Castaldi | |
| Glen Williams |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Hill Path Investment Holdings LLC
✚
|
0.0 | |
|
Aristos Ventures II LP
✚
|
0.0 | |
|
Arizona Isotope Science Research Corp.
✚
|
0.0 | |
|
OZFund, Inc.
✚
|
0.0 | |
|
HV Bancorp, Inc.
✚
|
0.0 | |
|
Hill Path Capital Partners LP
✚
|
0.0 | |
|
Hill Path D Fund LP
✚
|
0.0 | |
|
i02Bw Fund, LP
✚
|
0.0 | |
|
Hill Path G Fund LP
✚
|
0.0 | |
|
Hill Path Capital Partners S GP LLC
✚
|
0.0 |